InspireMD, Inc.
NCM: NSPRLive Quote
📈 ZcoreAI Score
Our AI model analyzes InspireMD, Inc.'s price action across multiple timeframes using regression channels and statistical scoring.
Get NSPR Z-Score →About InspireMD, Inc.
Healthcare
Medical Devices
InspireMD, Inc., a medical device company, focuses on the development and commercialization of products for the treatment of carotid artery disease and other vascular conditions in the United States, Germany, Italy, Russia, Poland, and internationally. It offers MicroNet, a biocompatible polymer mesh material for medical implants, as well as for treating plaque prolapse and embolization; CGuard carotid embolic prevention system (EPS) for use in carotid artery applications; CGuard Prime Carotid Stent System; and SwitchGuard neuroprotection system to provide flow reversal of cerebral protection in carotid interventions, as well as treating acute stroke with tandem lesions. The company was founded in 2005 and is headquartered in Miami, Florida.
📊 Fundamental Analysis
InspireMD, Inc. demonstrates a profit margin of 0.0%, which is below the sector average, suggesting competitive pressure.
The company recently reported 61.6% revenue growth, which is well above average for the Healthcare sector.
Return on Equity (ROE) is -106.9%, which indicates that capital utilization is currently under pressure.
At a current price of $1.29, NSPR currently trades near the bottom of its 52-week range (1%), indicating potential value or weakness (Range: $1.28 - $2.93).
🏥 Financial Health
🔴
Profit Margin
Weak
✅
Debt/Equity
Excellent
✅
Revenue Growth
Excellent
🔴
Return on Equity
Weak
⚠️
Beta (Risk)
Moderate Volatility
Key Financials
Market Cap
$60.37M
Trailing P/E
--
Forward P/E
-2.13
Beta (5Y)
0.94
52W High
$2.93
52W Low
$1.28
Avg Volume
35K
Day High
Day Low